Explore more publications!
Healthcare Focus Minnesota
Submit Press Release

Healthcare Focus Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Focus Minnesota.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 3, 2025

Nyxoah Participera à la Conférence Stifel Healthcare 2025
November 3, 2025

Nyxoah Participera à la Conférence Stifel Healthcare 2025

Indeterminate GlobeNewswire
Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis
November 3, 2025

Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis

Indeterminate GlobeNewswire
Option Care Health to Participate in Upcoming Investor Conferences
November 3, 2025

Option Care Health to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
InnovAge Appoints Dr. Paul Taheri as Chief Medical Officer
November 3, 2025

InnovAge Appoints Dr. Paul Taheri as Chief Medical Officer

Indeterminate GlobeNewswire
Regeneron Announces Investor Conference Presentations
November 3, 2025

Regeneron Announces Investor Conference Presentations

Indeterminate GlobeNewswire
Pyxis Oncology to Participate in Upcoming Investor Conferences
November 3, 2025

Pyxis Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors
November 3, 2025

BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors

Indeterminate GlobeNewswire
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®
November 3, 2025

Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®

Indeterminate GlobeNewswire
BBOT to Participate in the Jefferies Global Healthcare Conference in London
November 3, 2025

BBOT to Participate in the Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire
iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week
November 3, 2025

iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week

Indeterminate GlobeNewswire
Castle Biosciences Launches AdvanceAD-Tx™ to Help Guide Systemic Treatment Decision Making in Patients with Moderate-to-Severe Atopic Dermatitis
November 3, 2025

Castle Biosciences Launches AdvanceAD-Tx™ to Help Guide Systemic Treatment Decision Making in Patients with Moderate-to-Severe Atopic Dermatitis

Indeterminate GlobeNewswire
Bitterroot Bio to Present Anti-CD47 Research at American Heart Association Annual Scientific Session 2025
November 3, 2025

Bitterroot Bio to Present Anti-CD47 Research at American Heart Association Annual Scientific Session 2025

Indeterminate GlobeNewswire
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November
November 3, 2025

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November

Indeterminate GlobeNewswire
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 3, 2025

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
November 3, 2025

Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

Indeterminate GlobeNewswire
ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
November 3, 2025

ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 3, 2025

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
TELA Bio Appoints William Plovanic to Board of Directors
November 3, 2025

TELA Bio Appoints William Plovanic to Board of Directors

Indeterminate GlobeNewswire
Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions
November 3, 2025

Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions

Indeterminate GlobeNewswire
NurExone Accepted into ARMI’s BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing
November 3, 2025

NurExone Accepted into ARMI’s BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions